期刊文献+

HER-2/neu胞外配体结合区2在大肠杆菌中可溶性表达及纯化 被引量:6

Soluble Expression and Purification of HER-2/neu Extracellular Receptor Ligand Domain 2
下载PDF
导出
摘要 用PCR技术扩增HER 2 neu胞外配体结合区 2 (RLD2 )cDNA ,并将扩增的基因片段克隆于硫氧还蛋白 (TrxA)原核表达载体中 ,获得TrxA RLD2融合蛋白的可溶性表达 .通过插入偶联翻译序列 ,实现TrxA与RLD2蛋白在大肠杆菌中的共表达 .表达产物经免疫印记检测可被抗HER 2 neu特异性抗体识别 .经离子交换层析和钴亲和层析纯化 ,RLD2蛋白的纯度达 90 % .用质谱法分析RLD2蛋白的分子量 ,与预期值相符 .结果表明 ,利用TrxA表达体系在大肠杆菌中获得了HER 2 HER 2/neu receptor ligand domain 2 (RLD2) cDNA was amplified by PCR, cloned into the prokaryotic expression vector containing thioredoxin A (TrxA) gene and expressed in soluble form as TrxA RLD2 fusion protein. TrxA and RLD2 was co expressed by inserting a tandem sequence of stop and start codon into the recombinant plasmid. Western blotting showed that the expressed protein could react with the specific antibody against proto oncoprotein HER 2/neu. With the application of DEAE Sepharose FF and cobalt based affinity resin, the purity of RLD2 obtained was over 90%. The purified protein was further subject to mass spectroscopy molecular weight monitoring, and the molecular weight of RLD2 protein was identical to that expected. By using TrxA expression system, the soluble expression of RLD2 protein was obtained with high efficiency.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2004年第2期171-175,共5页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金资助项目 (No.3 0 0 70 85 8) 国家高技术研究发展计划 (863计划 No .2 0 0 1AA2 15 0 81)资助~~
关键词 HER-2/NEU 配体结合区 原癌基因 硫氧还蛋白 大肠杆菌 可溶性表达 纯化 HER 2/neu oncogene, receptor ligand domain, thioredoxin,soluble expression, purification
  • 相关文献

参考文献8

  • 1Lohrisch C, Piccart M. An overview of HER2. Semin Oncol, 2001,28:3 - 11
  • 2Brennan P J, Kumagai T. Berezov A, Murali R, Greene MI, Kumogai T. HER2/neu: mechanisms of dimerization/oligomerization. Oncogene,2000,19(53) :6093 - 6101
  • 3Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Oda S. Prognostic value of c-erbB2 expression in breast cancer. J Surg Oncol, 2002, 79(4) :216 - 223
  • 4Disis M L, Schiffman K. Cancer vaccines targeting the HER2/neu oncogenie protein. Semin Oncol, 2001, 28:12 - 20
  • 5Nagy P, Jenei A, Damjanovich S, Jovin T M, Szolosi J. Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy. Pathol Oncol Res, 1999, 5(4):255- 271
  • 6LaVallie E R, DiBlasio E A, Kovacic S, Grant K L, Schendel P F,McCoy J M. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm.Biotechnology, 1993, 11(2): 187 ~ 193
  • 7Lockhart E, Griffin JF, Chinn N, Lavallie E, Buchan G. The cloning,expression and purification of cervine interleukin 2. Cytokine, 1996, 8(8) :603 - 612
  • 8Stoll V S, Manohar A V, Gillon W, MacFarlane E L, Hynes R C, Pai E F. A thioredoxin fusion protein of VanH, a D-lactate dehydrogenase from Enterococcus faecium: cloning, expression, purification, kinetic analysis, and crystallization. Protein Sci, 1998, 7

同被引文献62

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部